Table 2.
Indications for operative hysteroscopy and histology result by randomised treatment group
Self-administered vaginal placebo* (n = 34) | Self-administered vaginal misoprostol (n = 33) | |
---|---|---|
Indications for hysteroscopy | ||
Asymptomatic endometrial polyp or leiomyoma, n (%) | 18 (52.9) | 18 (54.5) |
Postmenopausal bleeding and endometrial polyp, n (%) | 13 (38.2) | 11 (33.3) |
Lower abdominal pain and endometrial polyp, n (%) | 2 (5.9) | 2 (6.1) |
Vaginal discharge and endometrial polyp, n (%) | – | 2 (6.1) |
Removal of intrauterine device, n (%) | 1 (2.9) | – |
Histology results | ||
Benign histology, n (%) | 28 (82.4) | 27 (81.8) |
Complex endometrial hyperplasia with atypia, n (%) | 2 (5.9) | 3 (9.1) |
Complex endometrial hyperplasia without atypia, n (%) | 1 (2.9) | 1 (3.0) |
Simple endometrial hyperplasia, n (%) | 1 (2.9) | 1 (3.0) |
Endometrial adenocarcinoma, n (%) | 1 (2.9) | 1 (3.0) |